TMEM184B antibody (C-Term)
Quick Overview for TMEM184B antibody (C-Term) (ABIN500976)
Target
See all TMEM184B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody detects TMEM184B near C-term.
-
Purification
- Peptide affinity chromatography
-
Immunogen
- TMEM184B antibody was raised against a 15 amino acid peptide near the carboxy terminus of human TMEM184B.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- TMEM184B (Transmembrane Protein 184B (TMEM184B))
-
Alternative Name
- TMEM184B
-
Background
- TMEM184B, also known as C22orf5, is a 407 amino acid multi-pass membrane protein and represents a novel gene in the activation of the MAPK signaling pathway. The gene encoding TMEM184B maps to human chromosome 22, mutations in several of the genes in chromosome 22 are involved in the development of autism, schizophrenia, Phelan-McDermid syndrome and Neurofibromatosis type 2, suggesting that TMEM184B may play a role in these syndromes.Synonyms: C22orf5, Putative MAPK-activating protein FM08, Transmembrane protein 184B
-
Gene ID
- 25829
-
NCBI Accession
- NP_036396
Target
-